scholarly journals Percutaneous closure of an acquired and iatrogenic left ventricular–right atrium communication (Gerbode defect) with an Amplatzer Vascular Plug II

2020 ◽  
Vol 21 (1) ◽  
pp. 24-27
Author(s):  
Roberto Mijangos-Vázquez ◽  
Rogelio Hernández-Reyes ◽  
José R. López-Jiménez
Keyword(s):  
Right Atrium ◽  
Left Ventricular ◽  
Percutaneous Closure ◽  
Amplatzer Vascular Plug ◽  
Vascular Plug ◽  
Gerbode Defect ◽  
Amplatzer Vascular Plug Ii

Transcatheter closure of post-operative type 1 Gerbode defect by Amplatzer Duct Occluder 2

2021 ◽  
pp. 1-3
Author(s):  
Ahmet Vedat Kavurt ◽  
İbrahim Ece ◽  
Denizhan Bağrul
Keyword(s):  
Transcatheter Closure ◽  
Left Ventricular ◽  
Amplatzer Vascular Plug ◽  
Right Atrial ◽  
Amplatzer Duct Occluder ◽  
Vascular Plug ◽  
Gerbode Defect ◽  
Amplatzer Vascular Plug Ii

Abstract Acquired and congenital left ventricular to right atrial communication is rare, but nowadays, the frequency of the iatrogenic subgroup is increasing. Successful transcatheter closure of these defects with different devices has been reported. Herein, we presented successful closure of left ventricular to right atrial communication with Amplatzer Duct Occluder 2 after attempting to close with a failed Amplatzer Vascular Plug II device in a 7-year-old girl. This report supports that transcatheter closure of iatrogenic Gerbode defect with Amplatzer Duct Occluder 2 device is safe and effective.

Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer Vascular Plug-II

2015 ◽  
Vol 26 (6) ◽  
pp. 1194-1201 ◽  
Author(s):  
Nancy Hua ◽  
Paolo Aquino ◽  
Carl Y. Owada
Keyword(s):  
Transcatheter Closure ◽  
Left Ventricular ◽  
Defect Size ◽  
Amplatzer Vascular Plug ◽  
Ventricular Septal Defects ◽  
Vascular Plug ◽  
Effective Treatment Option ◽  
Septal Defects ◽  
Amplatzer Vascular Plug Ii

AbstractObjectiveThe aim of this study was to evaluate the safety and efficacy of the Amplatzer Vascular Plug-II used for the closure of perimembranous ventricular septal defects.BackgroundThere are no FDA-approved transcatheter devices for the closure of perimembranous ventricular septal defects. Several studies have reported on the use of various devices either off-label or under clinical trial protocols. However these reports have described significant adverse events including residual shunts, complete heart block, arrhythmia, and new valve regurgitations. Thus far, no study on the Amplatzer Vascular Plug-II has been reported.MethodsWe conducted a 4-year retrospective chart review from August, 2010 to August, 2014, of patients with perimembranous ventricular septal defects associated with ventricular septal aneurysm who underwent transcatheter closure using the Amplatzer Vascular Plug-II.ResultsA total of 16 patients underwent Amplatzer Vascular Plug-II transcatheter closure of their perimembranous ventricular septal defects. The median age was 2.56 years (range: 0.5–27.3). Their median weight was 13.0 kg (range: 6.9–71.6). The left ventricular median defect size was 9.3 mm (range: 5.9–14.4). The right ventricular median defect size was 3.6 mm (range: 2.3–5.8). All the patients underwent successful device implantation with 83% of the patients having complete echocardiographic closure at the 1-year follow-up; however, one procedure was complicated by early device embolisation. The device was successfully retrieved and replaced with a larger device. There were no device-related outflow tract obstructions, rhythm abnormalities, or haemolysis.ConclusionApplication of the Amplatzer Vascular Plug-II for closure of perimembranous ventricular septal defects appears to be a safe and effective treatment option. Prospective clinical trials and longer follow-up periods are warranted.

Transcatheter closure of elongated and pulmonary hypertensive patent arterial duct in infants using Amplatzer vascular plug II

2020 ◽  
Vol 30 (2) ◽  
pp. 243-248 ◽  
Author(s):  
Sneha M. Jain ◽  
Priya M. Pradhan ◽  
Supratim Sen ◽  
Bharat V. Dalvi
Keyword(s):  
Pulmonary Artery ◽  
Amplatzer Vascular Plug ◽  
Successful Outcome ◽  
Pulmonary Artery Stenosis ◽  
Amplatzer Duct Occluder ◽  
Vascular Plug ◽  
Arterial Duct ◽  
Duct Diameter ◽  
Patent Arterial Duct ◽  
Amplatzer Vascular Plug Ii

AbstractObjective:To evaluate the feasibility, efficacy, and safety of Amplatzer vascular plug II in large and elongated ducts in infants.Introduction:Patent arterial duct device closure is technically challenging in infants with large and elongated ducts because Amplatzer duct occluder and Amplatzer duct occluder II have high chances of causing aortic coarctation and left pulmonary artery stenosis, respectively. The Amplatzer vascular plug II being soft with no retention discs on either sides helps in mitigating these problems.Method:This is a prospective, observational study involving infants with clinical, echocardiographic and angiographic evidence of large left to right shunt. All the children underwent duct closure using Amplatzer vascular plug II.Results:Eighteen infants qualified for the study. Mean age and weight were 8.63 ± 3.84 months and 6.3 ± 1.7 kg, respectively. The angiographic mean duct diameter at the pulmonary artery end was 4.66 ± 0.92 mm, and the mean duct length was 9.4 ± 2.48 mm. The size of Amplatzer vascular plug II used varied from 6 mm to 10 mm. Technical success was achieved in 16/18 cases. One patient had device embolisation, and in the other, the device was found to be unstable. The ratio of Amplatzer vascular plug II size to the duct diameter was 1.65 ± 0.27, while the ratio of ductal length to device length was 1.48 ± 0.46 in those with successful outcome.Conclusions:Amplatzer vascular plug II is a safe and effective option in appropriately selected infants with elongated ducts. Diameter and length of Amplatzer vascular plug II vis-a-vis those of the ductus are important determinants of the successful outcome.

Sign in / Sign up

Export Citation Format

Share Document